CD4 and hepatocellular carcinoma: Additionally, significant differences were observed in the percentages of B cells (HCC: BLD= 13.6% vs. 11.8%, p = 0.047) and CD4+ T cells (HCC: BLD= 40.4% vs. 42.8%, p = 0.042) between the HCC and BLD groups (Figure 1C,D).